PROM1 and glioblastoma: Then, CD133 was identified as a CSC marker in hepatocellular carcinoma (HCC),12 glioblastoma,13 colon tumors7 and ovarian cancers (OCs).14 However, CD133 alone cannot always indicate the CSC phenotype.